{"result": ["POSES SAFETY", "BLEEDING RISK PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION", "NCT01385319", "PRIMARY ENDPOINT", "UNSTABLE CORONARY ARTERY DISEASE", "STENT GROUPS", "ZEUS", "HBR", "DUAL ANTIPLATELET THERAPY", "DAPT", "PROBABLE STENT THROMBOSIS", "BMS", "SUPERIOR EFFICACY", "E-ZES", "MAJOR ADVERSE CARDIOVASCULAR EVENTS", "BARE-METAL STENT", "ENDEAVOR SPRINT", "PRO-HEMORRHAGIC MEDICATIONS", "HAZARD RATIO", "MYOCARDIAL INFARCTION", "12-MONTH MAJOR ADVERSE CARDIOVASCULAR EVENT RATE", "DES", "ORAL ANTICOAGULANTS", "UNCERTAIN DES CANDIDATES", "BARE-METAL STENT IMPLANTATION"]}